Guangdong Hengrui Pharmaceutical Co., Ltd

This study tests an experimental drug called SHR-1139 in 20 adults with pyoderma gangrenosum, a rare condition causing painful skin ulcers. The main goal is to see if the drug can completely close the largest ulcer and keep it closed. Researchers will also check for side effects …

This study is testing whether an investigational injection called SHR-2173 can help control IgA nephropathy, a kidney disease where protein leaks into the urine. About 84 adult patients will receive either the real injection or a placebo (dummy shot) for 48 weeks to see if it saf…

This early-stage study tests whether a new inhaled powder called HRS-9821 is safe for people with COPD. It will first give a single dose to healthy volunteers, then multiple doses to COPD patients. The main goal is to check for side effects, not to treat the disease yet.